InvestorsHub Logo
Followers 3
Posts 966
Boards Moderated 0
Alias Born 03/30/2021

Re: None

Tuesday, 02/27/2024 4:50:37 AM

Tuesday, February 27, 2024 4:50:37 AM

Post# of 5331
25,000 device installations worldwide.
Ophthalmology Breaking News.

Maybe not an "Apples to Apples" comparison to AXIM. However AXIM/Verséa are selling to the same offices as Optos.

I paid $30 to have pictures taken of my retinas last time I had my eyes checked.

Advantages:
*** No pupil dilation
*** better image capture.
*** Doctor keeps image for future reference
Win-Win.


25,000 global device installations.
The AXIM/Verséa Ophthalmics test-reader device is not a 1-trick pony. Two existing FDA cleared 510K tests. MMP-9 510K announced as available in 15 months. Maybe other tests to follow.



https://ophthalmologybreakingnews.com/optos-celebrates-device-installations-worldwide-clinical-studies


Optos's unique position in the market is highlighted by its proprietary single-capture, 200-degree, ultra-widefield retinal imaging technology. This technology is pivotal for diagnosing and managing a broad spectrum of ocular conditions, enhancing the detection and diagnosis processes.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News